risedronic acid has been researched along with Hemangiosarcoma in 2 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Hemangiosarcoma: A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kambayashi, Y | 2 |
| Fujimura, T | 2 |
| Furudate, S | 2 |
| Hashimoto, A | 1 |
| Haga, T | 1 |
| Aiba, S | 2 |
| Kakizaki, A | 1 |
2 other studies available for risedronic acid and Hemangiosarcoma
| Article | Year |
|---|---|
Comparison of immunosuppressive and cytotoxic cells in angiosarcoma: development of a possible supportive therapy for angiosarcoma.
Topics: Aged; Aged, 80 and over; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antigens, Differen | 2013 |
Immunomodulatory effect of bisphosphonate risedronate sodium on CD163+ arginase 1+ M2 macrophages: the development of a possible supportive therapy for angiosarcoma.
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Arginase; Calcium Channel Blockers; Cytokin | 2013 |